Alexander W. MacFarlane, Ph.D. - Publications

Affiliations: 
Temple University, Philadelphia, PA, United States 

4/99 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Franzen S, Jasaitis A, Belyea J, Brewer SH, Casey R, MacFarlane AW, Stanley RJ, Vos MH, Martin JL. Hydrophobic distal pocket affects NO-heme geminate recombination dynamics in dehaloperoxidase and H64V myoglobin. The Journal of Physical Chemistry. B. 110: 14483-93. PMID 16854160 DOI: 10.1021/Jp056790M  0.451
2003 MacFarlane AW, Stanley RJ. Cis-syn thymidine dimer repair by DNA photolyase in real time. Biochemistry. 42: 8558-68. PMID 12859203 DOI: 10.1021/Bi034015W  0.493
2002 Christine KS, MacFarlane AW, Yang K, Stanley RJ. Cyclobutylpyrimidine dimer base flipping by DNA photolyase. The Journal of Biological Chemistry. 277: 38339-44. PMID 12169694 DOI: 10.1074/Jbc.M206531200  0.454
2001 MacFarlane AW, Stanley RJ. Evidence of powerful substrate electric fields in DNA photolyase: implications for thymidine dimer repair. Biochemistry. 40: 15203-14. PMID 11735403 DOI: 10.1021/bi0114224  0.508
Low-probability matches (unlikely to be authored by this person)
1996 Macfarlane AW, Parry DH, Caslin AW, Hughes M. Cutaneous lesions in a case of acute megakaryoblastic leukaemia. Clinical and Experimental Dermatology. 21: 201-4. PMID 8914360  0.131
1878 Macfarlane A. XXIII.—On the Disruptive Discharge of Electricity: An Experimental Thesis for the Degree of Doctor of Science, Department A Transactions of the Royal Society of Edinburgh. 28: 633-671. DOI: 10.1017/S0080456800090438  0.072
2017 Pazina T, James AM, MacFarlane AW, Bezman NA, Henning KA, Bee C, Graziano RF, Robbins MD, Cohen AD, Campbell KS. The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanisms. Oncoimmunology. 6: e1339853. PMID 28932638 DOI: 10.1080/2162402X.2017.1339853  0.064
1991 Yu RC, Pryce DW, Macfarlane AW, Stewart TW. A histopathological study of 643 cutaneous horns. The British Journal of Dermatology. 124: 449-52. PMID 2039721 DOI: 10.1111/j.1365-2133.1990.tb04455.x  0.063
2014 Potra A, Macfarlane AW. Lead isotope studies of the Guerrero composite terrane, west-central Mexico: Implications for ore genesis Mineralium Deposita. 49: 101-117. DOI: 10.1007/S00126-013-0477-0  0.062
2013 Macfarlane A, Bagnyukova TV, Campbell K, Jones B, Bachovchin W, Borghaei H. Immunomodulatory effects of a dipeptidyl peptidase inhibitor, ARI-4175, and NK cell activation in a colon cancer model. Journal of Clinical Oncology. 31: 3058-3058. DOI: 10.1200/Jco.2013.31.15_Suppl.3058  0.062
1987 Lewis-Jones MS, Barnes RM, MacFarlane AW, Curley RK, Johnson PM, Finn R. Frequency and isotype distribution of serum antibodies reactive with dietary proteins in adults with chronic urticaria. Clinical and Experimental Dermatology. 12: 419-23. PMID 3504749  0.061
1893 MacFarlane A, Pierce GW. On the electric strength of solid, liquid, and gaseous dielectrics Physical Review (Series I). 1: 161-165. DOI: 10.1103/PhysRevSeriesI.1.161  0.057
2006 Cohen RA, Grieve S, Hoth KF, Paul RH, Sweet L, Tate D, Gunstad J, Stroud L, McCaffery J, Hitsman B, Niaura R, Clark CR, McFarlane A, MacFarlane A, Bryant R, et al. Early life stress and morphometry of the adult anterior cingulate cortex and caudate nuclei. Biological Psychiatry. 59: 975-82. PMID 16616722 DOI: 10.1016/J.Biopsych.2005.12.016  0.056
2014 Macfarlane AW, Lechtman HN. Andean Ores, Bronze Artifacts, and Lead Isotopes: Constraints on Metal Sources in Their Geological Context Journal of Archaeological Method and Theory. DOI: 10.1007/S10816-014-9225-8  0.056
1986 Curley RK, MacFarlane AW, King CM. Contact dermatitis to 2, phenyl tetralone tosylhydrazone. Contact Dermatitis. 14: 257-8. PMID 2941234 DOI: 10.1111/J.1600-0536.1986.TB01245.X  0.056
2012 Panneerselvam K, Macfarlane AW, Salters VJM. Reconnaissance lead isotope characteristics of the blackbird deposit: Implications for the age and origin of cobalt-copper mineralization in the Idaho cobalt belt, United States Economic Geology. 107: 1177-1188. DOI: 10.2113/Econgeo.107.6.1177  0.053
1991 Macfarlane AW, Chapman SJ, Verbov JL. Is erythrokeratoderma one disorder? A clinical and ultrastructural study of two siblings. The British Journal of Dermatology. 124: 487-91. PMID 1828175  0.053
2016 Kaileh M, Vazquez E, MacFarlane AW, Campbell K, Kurosaki T, Siebenlist U, Sen R. mTOR-Dependent and Independent Survival Signaling by PI3K in B Lymphocytes. Plos One. 11: e0146955. PMID 26785352 DOI: 10.1371/journal.pone.0146955  0.052
1987 Macfarlane AW, Davenport A, Verbov JL, Goldsmith HJ. Scleromyxoedema--successful treatment with plasma exchange and immunosuppression. The British Journal of Dermatology. 117: 653-7. PMID 3689684 DOI: 10.1111/j.1365-2133.1987.tb07499.x  0.052
1991 MacFarlane AW, Holland HD. The timing of alkali metasomatism in paleosols. Canadian Mineralogist. 29: 1043-50. PMID 11538177  0.048
1880 Macfarlane A. 5. Suggestions on the Art of Signalling Proceedings of the Royal Society of Edinburgh. 10: 698-700. DOI: 10.1017/S0370164600044503  0.048
2015 Ge MQ, Kokalari B, Flayer CH, Killingbeck SS, Redai IG, MacFarlane AW, Hwang JW, Kolupoti A, Kemeny MD, Campbell KS, Haczku A. Cutting Edge: Role of NK Cells and Surfactant Protein D in Dendritic Cell Lymph Node Homing: Effects of Ozone Exposure. Journal of Immunology (Baltimore, Md. : 1950). PMID 26673133 DOI: 10.4049/jimmunol.1403042  0.048
2021 MacFarlane AW, Yeung HM, Alpaugh RK, Dulaimi E, Engstrom PF, Dasari A, Campbell KS, Vijayvergia N. Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms. Cancer Immunology, Immunotherapy : Cii. PMID 33398390 DOI: 10.1007/s00262-020-02811-5  0.048
2006 Cohen RA, Hitsman BL, Paul RH, McCaffery J, Stroud L, Sweet L, Gunstad J, Niaura R, MacFarlane A, Bryant RA, Gordon E. Early life stress and adult emotional experience: an international perspective. International Journal of Psychiatry in Medicine. 36: 35-52. PMID 16927577 DOI: 10.2190/5R62-9Pqy-0Nel-Tlpa  0.046
1990 Yu RC, Macfarlane AW, King CM. An unusual delayed patch test reaction to para-tertiary-butylcatechol. Contact Dermatitis. 22: 110-1. PMID 2323196 DOI: 10.1111/j.1600-0536.1990.tb01531.x  0.046
1988 Macfarlane AW, Field EA. Skin conditions affecting the dental surgeon's hand. Dental Update. 15: 383-5. PMID 3272912  0.046
1994 MacFarlane AW, Danielson A, Holland HD, Jacobsen SB. REE chemistry and Sm-Nd systematics of late Archean weathering profiles in the Fortescue Group, Western Australia. Geochimica Et Cosmochimica Acta. 58: 1777-94. PMID 11539148 DOI: 10.1016/0016-7037(94)90536-3  0.045
2017 Zibelman MR, Macfarlane A, Alpaugh RK, Dulaimi E, Costello K, O'Neill J, Borghaei H, Denlinger CS, Geynisman DM, Dotan E, Jain A, Martin LP, Obeid E, Nieves JA, Crouteau D, et al. Effect of exogenous interferon-gamma (IFN-gamma) on peripheral blood immune markers as part of a phase I clinical trial of combined IFN-gamma with nivolumab (Nivo) in patients (pts) with select solid tumors. Journal of Clinical Oncology. 35: 97-97. DOI: 10.1200/jco.2017.35.7_suppl.97  0.045
1878 Macfarlane A, Playfair PM. 1. On the Disruptive Discharge of Electricity Proceedings of the Royal Society of Edinburgh. 9: 721-723. DOI: 10.1017/S0370164600033460  0.045
2012 Ni M, MacFarlane AW, Toft M, Lowell CA, Campbell KS, Hamerman JA. B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K. Proceedings of the National Academy of Sciences of the United States of America. 109: 267-72. PMID 22187458 DOI: 10.1073/Pnas.1111957108  0.045
2016 Ge MQ, Kokalari B, Flayer CH, Killingbeck SS, Redai IG, MacFarlane AW, Hwang JW, Kolupoti A, Kemeny DM, Campbell KS, Haczku A. Correction: Cutting Edge: Role of NK Cells and Surfactant Protein D in Dendritic Cell Lymph Node Homing: Effects of Ozone Exposure. Journal of Immunology (Baltimore, Md. : 1950). 196: 3212. PMID 26994305 DOI: 10.4049/jimmunol.1600095  0.045
2017 Obeid E, Zhou C, Macfarlane A, Alpaugh RK, McAleer C, Dulaimi E, Campbell K, Goldstein LJ. Combining chemotherapy and programmed death 1 (PD-1) blockade to induce a T-cell response in patients with metastatic triple negative breast cancer (mTNBC). Journal of Clinical Oncology. 35: 11563-11563. DOI: 10.1200/jco.2017.35.15_suppl.11563  0.044
2022 Zhigarev D, Varshavsky A, MacFarlane AW, Jayaguru P, Barreyro L, Khoreva M, Dulaimi E, Nejati R, Drenberg C, Campbell KS. Lymphocyte Exhaustion in AML Patients and Impacts of HMA/Venetoclax or Intensive Chemotherapy on Their Biology. Cancers. 14. PMID 35884414 DOI: 10.3390/cancers14143352  0.043
1887 Macfarlane A. The Logical Form of Geometrical Theorems The Annals of Mathematics. 3: 154. DOI: 10.2307/1967561  0.043
1880 Macfarlane A. 4. On a Calculus of Relationship Proceedings of the Royal Society of Edinburgh. 10: 224-232. DOI: 10.1017/S0370164600043674  0.043
2005 Konstantopoulou M, Belgi A, Griffiths KD, Seale JRC, Macfarlane AW. Azathioprine-induced pancytopenia in a patient with pompholyx and deficiency of erythrocyte thiopurine methyltransferase British Medical Journal. 330: 350-351. PMID 15705694  0.042
2009 Gitelson E, MacFarlane AW, Campbell KS, Alpaugh RK, Al-Saleem TI, Smith MR. Immune Function in Follicular Lymphoma (FL): Comparison of Patient with Her Healthy Identical Twin Reveals Enhanced NK Cell Responses in the Patient During Spontaneous Remission [KC1]. Blood. 114: 5012-5012. DOI: 10.1182/blood.v114.22.5012.5012  0.042
2023 Zibelman M, MacFarlane AW, Costello K, McGowan T, O'Neill J, Kokate R, Borghaei H, Denlinger CS, Dotan E, Geynisman DM, Jain A, Martin L, Obeid E, Devarajan K, Ruth K, et al. A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors. Nature Communications. 14: 4513. PMID 37500647 DOI: 10.1038/s41467-023-40028-z  0.041
1989 Macfarlane AW, Curley RK, Graham RM, Lewis-Jones MS, King CM. Delayed patch test reactions at days 7 and 9. Contact Dermatitis. 20: 127-32. PMID 2706961 DOI: 10.1111/j.1600-0536.1989.tb03121.x  0.041
2016 Haseebuddin M, Macfarlane A, Ruth K, Uzzo RG, Plimack ER, Jillab M, Dulaimi E, Al-Saleem TI, Campbell K. PD-1 expression on classical monocytes (CM) as an independent predictor of cancer specific survival in clear cell renal carcinoma (ccRCC). Journal of Clinical Oncology. 34: 562-562. DOI: 10.1200/jco.2016.34.2_suppl.562  0.04
2012 Cole ME, MacFarlane A, Jillab M, Smith MR, Cohen AD, Campbell K. Immune Cell Dysfunction in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Blood. 120: 3875-3875. DOI: 10.1182/blood.v120.21.3875.3875  0.039
1985 Macfarlane AW, Verbov JL. Necrobiotic xanthogranuloma with paraproteinaemia. The British Journal of Dermatology. 113: 339-43. PMID 4063169  0.038
1985 Curley RK, Macfarlane AW, Vickers CF. Pyoderma gangrenosum treated with cyclosporin A. The British Journal of Dermatology. 113: 601-4. PMID 4063193  0.038
1990 Macfarlane AW, Yu RC, King CM. Contact sensitivity to para-tertiary-butylcatechol in an artificial limb. Contact Dermatitis. 22: 56-7. PMID 2323190 DOI: 10.1111/j.1600-0536.1990.tb01511.x  0.037
2015 Pazina T, MacFarlane A, Mentik-James A, Yam C, Kotcher R, Campbell KS, Cohen AD. The Phenotype of Natural Killer (NK) Cells in Multiple Myeloma (MM) Patients: Impact on Ex Vivo Responsiveness to the Anti-SLAMF7 Antibody, Elotuzumab Blood. 126: 3024-3024. DOI: 10.1182/blood.V126.23.3024.3024  0.037
1987 Ng HW, Macfarlane AW, Graham RM, Verbov JL. Near fatal drug interactions with methotrexate given for psoriasis. British Medical Journal (Clinical Research Ed.). 295: 752-3. PMID 3119023  0.036
1986 Curley RK, Macfarlane AW, King CM. Contact sensitivity to the amide anesthetics lidocaine, prilocaine, and mepivacaine. Case report and review of the literature. Archives of Dermatology. 122: 924-6. PMID 3740877  0.035
1989 MacFarlane AW. A case of actinic lichen planus. Clinical and Experimental Dermatology. 14: 65-8. PMID 2805391  0.034
2014 Potra A, Hickey-Vargas R, Macfarlane AW, Salters VJM. Pb, Sr, and Nd isotopic characteristics of a variety of lithologies from the Guerrero composite terrane, west-central Mexico: Constraints on their origin Revista Mexicana De Ciencias Geologicas. 31: 203-220.  0.033
2014 MacFarlane AW, Jillab M, Smith MR, Alpaugh RK, Cole ME, Litwin S, Millenson MM, Al-Saleem TI, Cohen AD, Campbell KS. Natural Killer Cell Dysfunction in Chronic Lymphocytic Leukemia Is Associated with Loss of the Mature KIR3DL1+ Subset Blood. 124: 3318-3318. DOI: 10.1182/blood.V124.21.3318.3318  0.032
2018 Wagner J, Kline CL, Zhou L, Campbell KS, MacFarlane AW, Olszanski AJ, Cai KQ, Hensley HH, Ross EA, Ralff MD, Zloza A, Chesson CB, Newman JH, Kaufman H, Bertino JR, et al. Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment. The Journal of Clinical Investigation. PMID 29533922 DOI: 10.1172/Jci96711  0.032
2010 MacFarlane AW, Oesterling JF, Campbell KS. Measuring intracellular calcium signaling in murine NK cells by flow cytometry. Methods in Molecular Biology (Clifton, N.J.). 612: 149-57. PMID 20033639 DOI: 10.1007/978-1-60761-362-6_10  0.031
1986 MacFarlane AW, Curley RK, King CM. Contact sensitivity to unsaturated polyester resin in a limb prosthesis. Contact Dermatitis. 15: 301-3. PMID 3816194  0.03
2006 Panneerselvam K, MacFarlane AW, Salters VJM. Provenance of ore metals in base and precious metal deposits of central Idaho as inferred from lead isotopes Economic Geology. 101: 1063-1077. DOI: 10.2113/Gsecongeo.101.5.1063  0.03
2021 Pazina T, MacFarlane AW, Bernabei L, Dulaimi E, Kotcher R, Yam C, Bezman NA, Robbins MD, Ross EA, Campbell KS, Cohen AD. Alterations of NK Cell Phenotype in the Disease Course of Multiple Myeloma. Cancers. 13. PMID 33435153 DOI: 10.3390/cancers13020226  0.028
1902 Macfarlane A. Peter Guthrie Tait Physical Review (Series I). 15: 51-64. DOI: 10.1103/PhysRevSeriesI.15.51  0.028
2019 Barta SK, Zain J, MacFarlane AW, Smith SM, Ruan J, Fung HC, Tan CR, Yang Y, Alpaugh RK, Dulaimi E, Ross EA, Campbell KS, Khan N, Siddharta R, Fowler NH, et al. Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma. Clinical Lymphoma, Myeloma & Leukemia. PMID 31029646 DOI: 10.1016/j.clml.2019.03.022  0.027
2017 MacFarlane AW, Jillab M, Smith MR, Alpaugh RK, Cole ME, Litwin S, Millenson MM, Al-Saleem T, Cohen AD, Campbell KS. NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors. Oncoimmunology. 6: e1330235. PMID 28811973 DOI: 10.1080/2162402X.2017.1330235  0.026
2022 Ford JW, Gonzalez-Cotto M, MacFarlane AW, Peri S, Howard OMZ, Subleski JJ, Ruth KJ, Haseebuddin M, Al-Saleem T, Yang Y, Rayman P, Rini B, Linehan WM, Finke J, Weiss JM, et al. Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell Carcinoma. Frontiers in Oncology. 11: 662723. PMID 35223446 DOI: 10.3389/fonc.2021.662723  0.026
2009 Konstantopoulou M, Oliver TI, Lord MG, Macfarlane AW. Papular eruption in an elderly woman. Clinical and Experimental Dermatology. 34: 277-8. PMID 19187317 DOI: 10.1111/j.1365-2230.2008.02841.x  0.026
2017 Finnberg NK, Gokare P, Lev A, Grivennikov SI, MacFarlane AW, Campbell KS, Winters RM, Kaputa K, Farma JM, Abbas AE, Grasso L, Nicolaides NC, El-Deiry WS. Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures. Oncotarget. 8: 66747-66757. PMID 28977993 DOI: 10.18632/Oncotarget.19965  0.025
1987 Macfarlane AW, Curley RK. Management of toxic epidermal necrolysis with a hydrogel dressing and fluidized-bead bed: report of three cases. Clinical and Experimental Dermatology. 12: 354-6. PMID 3446423  0.025
2023 Jang HJ, Hostetter G, MacFarlane AW, Madaj Z, Ross EA, Hinoue T, Kulchycki JR, Burgos RS, Tafseer M, Alpaugh RK, Schwebel CL, Kokate R, Geynisman DM, Zibelman MR, Ghatalia P, et al. A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 36928921 DOI: 10.1158/1078-0432.CCR-22-3642  0.025
2022 Macfarlane A, Duquin TR. Different Surgeries, Same Result?: Commentary on an article by Jacob M. Kirsch, MD, et al.: "Outcomes After Anatomic and Reverse Shoulder Arthroplasty for the Treatment of Glenohumeral Osteoarthritis. A Propensity Score-Matched Analysis". The Journal of Bone and Joint Surgery. American Volume. 104: e68. PMID 35924952 DOI: 10.2106/JBJS.22.00558  0.025
2008 MacFarlane AW, Yamazaki T, Fang M, Sigal LJ, Kurosaki T, Campbell KS. Enhanced NK-cell development and function in BCAP-deficient mice. Blood. 112: 131-40. PMID 18337558 DOI: 10.1182/blood-2007-08-107847  0.024
1880 Macfarlane A. 6. On the Solution of the Simultaneous Equations:— ax + by = c, and dx + ey = f, when the Symbols denote Qualities Proceedings of the Royal Society of Edinburgh. 10: 283-283. DOI: 10.1017/S037016460004387X  0.024
1987 MacFarlane AW. Cross reaction to a Christmas tree. British Medical Journal (Clinical Research Ed.). 295: 1660-1. PMID 3121124  0.024
1988 Smith SR, Macfarlane AW, Lewis-Jones MS. Papular urticaria and transfer of allergy following bone marrow transplantation. Clinical and Experimental Dermatology. 13: 260-2. PMID 3073029  0.023
2014 MacFarlane AW, Jillab M, Plimack ER, Hudes GR, Uzzo RG, Litwin S, Dulaimi E, Al-Saleem T, Campbell KS. PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection. Cancer Immunology Research. 2: 320-31. PMID 24764579 DOI: 10.1158/2326-6066.CIR-13-0133  0.023
2006 MacFarlane AW, Campbell KS. Signal transduction in natural killer cells. Current Topics in Microbiology and Immunology. 298: 23-57. PMID 16329184  0.022
2011 Harper Smith AD, Coakley SL, Ward MD, Macfarlane AW, Friedmann PS, Walsh NP. Exercise-induced stress inhibits both the induction and elicitation phases of in vivo T-cell-mediated immune responses in humans. Brain, Behavior, and Immunity. 25: 1136-42. PMID 21362469 DOI: 10.1016/j.bbi.2011.02.014  0.021
1897 MACFARLANE A. A Primer of Quaternions Science. 5: 699-701. DOI: 10.1126/science.5.122.699-c  0.02
2020 Fernandez SV, MacFarlane AW, Jillab M, Arisi MF, Yearley J, Annamalai L, Gong Y, Cai KQ, Alpaugh RK, Cristofanilli M, Campbell KS. Immune phenotype of patients with stage IV metastatic inflammatory breast cancer. Breast Cancer Research : Bcr. 22: 134. PMID 33267869 DOI: 10.1186/s13058-020-01371-x  0.019
2019 Smoak JB, Macfarlane A, Kluczynski MA, Ferrick MR, Doak JP, Bisson LJ, Marzo JM. Postoperative radiographic observations following transphyseal anterior cruciate ligament reconstruction in skeletally immature patients. Skeletal Radiology. 49: 861-868. PMID 31848655 DOI: 10.1007/s00256-019-03361-3  0.019
2016 Haseebuddin M, MacFarlane A, Ruth K, Uzzo R, Plimack E, Jillab M, Dulaimi E, Al-Saleem T, Campbell K. MP92-03 B-LYMPHOCYTES (BL) DIFFERENTIATION IS ATYPICAL IN CLEAR CELL RENAL CELL CARCINOMA (CCRCC) AND LOW PREOPERATIVE BL COUNT IS ASSOCIATED WITH POOR CANCER SPECIFIC SURVIVAL (CSS) Journal of Urology. 195. DOI: 10.1016/j.juro.2016.02.2636  0.019
1989 MacFarlane AW. Inborn errors of lipid metabolism. Clinical and Experimental Dermatology. 14: 334. PMID 2629741  0.018
2016 Haseebuddin M, MacFarlane A, Ruth K, Uzzo R, Plimack E, JIllab M, Dulaimi E, Al-Saleem T, Campbell K, Haseebuddin M. MP92-01 PD-1 EXPRESSION ON CLASSICAL MONOCYTES (CM) IS AN INDEPENDENT PREDICTOR OF CANCER SPECIFIC SURVIVAL IN CLEAR CELL RENAL CARCINOMA (CCRCC) Journal of Urology. 195. DOI: 10.1016/j.juro.2016.02.2634  0.018
2011 Miah SM, Purdy AK, Rodin NB, MacFarlane AW, Oshinsky J, Alvarez-Arias DA, Campbell KS. Ubiquitylation of an internalized killer cell Ig-like receptor by Triad3A disrupts sustained NF-κB signaling. Journal of Immunology (Baltimore, Md. : 1950). 186: 2959-69. PMID 21270397 DOI: 10.4049/jimmunol.1000112  0.018
2014 MacFarlane A, Saikkonen K, McKim T. A Holistic Approach to Organics Co-Digestion: Harvest Power Orlando at Reedy Creek Improvement District Proceedings of the Water Environment Federation. 2014: 4538-4549. DOI: 10.2175/193864714815941090  0.016
1880 Macfarlane A. 2. The Principles of the Algebra of Logic. Part III.—Application to certain Problems in the Theory of Probability Proceedings of the Royal Society of Edinburgh. 10: 105-111. DOI: 10.1017/S0370164600043522  0.016
1989 Macfarlane AW, Verbov JL. Trauma-induced bullous pemphigoid. Clinical and Experimental Dermatology. 14: 245-9. PMID 2686871  0.014
2006 Konstantopoulou M, Andrady U, Lord MG, Macfarlane AW. Papulosquamous dermatitis. Syphilis: a forgotten disease? Dermatology Online Journal. 12: 27. PMID 17459313  0.013
1987 Graham RM, MacFarlane AW, Curley RK, Nash JR. Beta 2 microglobulin expression in keratoacanthomas and squamous cell carcinoma. The British Journal of Dermatology. 117: 441-9. PMID 3314969  0.011
2006 Konstantopoulou M, Lord MG, Macfarlane AW. Treatment of invasive squamous cell carcinoma with 5-percent imiquimod cream. Dermatology Online Journal. 12: 10. PMID 16638424  0.01
2005 Konstantopoulou M, O'Dwyer EM, Steele JC, Field EA, Lewis MA, Macfarlane AW. Pyodermatitis-pyostomatitis vegetans complicated by methicillin-resistant Staphylococcus aureus infection. Clinical and Experimental Dermatology. 30: 666-8. PMID 16197384 DOI: 10.1111/j.1365-2230.2005.01906.x  0.01
1997 Macfarlane AW. Human orf complicated by bullous pemphigoid. The British Journal of Dermatology. 137: 656-7. PMID 9390357  0.01
1987 Curley RK, Macfarlane AW, Evans S, Woodrow JC. The treatment of linear morphoea with D-penicillamine. Clinical and Experimental Dermatology. 12: 56-7. PMID 3652506  0.01
1985 Curley RK, Macfarlane AW. Fatal multisystemic toxicity associated with prophylaxis with pyrimethamine and sulfadoxine. British Medical Journal (Clinical Research Ed.). 290: 471-2. PMID 2857586  0.01
1960 MACFARLANE AW, MCKENZIE JS. The pharmacology of a new central nervous system stimulant, beta beta methyl isopropyl glutarimide. Archives Internationales De Pharmacodynamie Et De ThéRapie. 127: 379-401. PMID 13764773  0.01
1904 Macfarlane A. Book Review: Conceptos fundamentales de Analysis matematica Bulletin of the American Mathematical Society. 10: 515-516. DOI: 10.1090/s0002-9904-1904-01165-9  0.01
1899 Macfarlane A. A Treatise on Universal Algebra Science. 9: 324-328. DOI: 10.1126/science.9.218.324  0.01
1898 MACFARLANE A. La Mathematique; philosophie, enseignemnent Science. 8: 51-53. DOI: 10.1126/science.8.184.51-a  0.01
1897 MACFARLANE A. Utility of Quaternions in Physics Science. 5: 699-701. DOI: 10.1126/science.5.122.699-d  0.01
1897 MACFARLANE A. The Outlines of Quaternions Science. 5: 699-701. DOI: 10.1126/science.5.122.699-b  0.01
1895 Matteson J, Macfarlane A. Problems: 28-29 The American Mathematical Monthly. 2: 134. DOI: 10.2307/2970220  0.01
1895 Macfarlane A. Biography: Arthur Cayley The American Mathematical Monthly. 2: 99. DOI: 10.2307/2970187  0.01
1894 MacFarlane A, Shields FM. Problems: 42-43 The American Mathematical Monthly. 1: 433. DOI: 10.2307/2969046  0.01
1890 Macfarlane AW. Piratical American Publishers Bmj. 2: 925-925. DOI: 10.1136/bmj.2.1555.925-a  0.01
1889 Macfarlane A. NOTE ON THE THERAPEUTIC ACTION OF SENNA PODS. The Lancet. 134: 164-165. DOI: 10.1016/S0140-6736(02)29865-7  0.01
Hide low-probability matches.